Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients

G. A. Kim, T. H. Rim, Sungchul Lee, S. H. Byeon, H. J. Koh, S. S. Kim, C. S. Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

PurposeTo investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients.MethodsWe retrospectively reviewed 42 eyes of CSC patients of symptom duration more than 3 months who received a single or multiple successive IVBs on an as-needed basis (0.05 ml, 1.25 mg). High responders (HRs) were defined as complete resolution of subretinal fluid (SRF) on spectral domain optical coherence tomography (SD-OCT). Moderate responders (MRs) were defined as SRF resolution of 50-99% of pretreatment volume and poor responders (PRs) as SRF resolution <50%. Clinical, SD-OCT, fluorescein, and indocyanine green angiography findings were analyzed to find factors associated with HR. Descriptive statistics for all demographic and clinical variables were calculated, and comparisons were made using Wilcoxon's matched-pairs signed-rank test, the Mann-Whitney U-test for means with continuous data, Pearson's χ 2 test, and Fisher's exact test for categorical data.ResultsThe mean number of IVB was 1.9. At postoperative 1 month, there were 10 (24%) HRs, 18 (43%) MRs, and 14 (33%) PRs. At the last follow-up (the mean 8.6 months), there were 25 HRs (60%), 9 MRs (21%), and 8 PRs (19%). Thicker subfoveal choroid (P=0.036), smaller lesion diameter (P=0.019), and better baseline best-corrected visual acuity (P=0.002) predicted HRs at postoperative 1 month. HR at the last follow-up was associated with classic pattern fluorescein angiography finding.ConclusionsSuboptimal effects of IVB on persistent CSC suggest primary IVB on selective cases with better vision, smaller lesion, and thicker choroid at baseline.

Original languageEnglish
Pages (from-to)732-741
Number of pages10
JournalEye (Basingstoke)
Volume29
Issue number6
DOIs
Publication statusPublished - 2015 Jun 12

Fingerprint

Central Serous Chorioretinopathy
Subretinal Fluid
Choroid
Optical Coherence Tomography
Indocyanine Green
Fluorescein Angiography
Nonparametric Statistics
Fluorescein
Visual Acuity
Angiography
Demography
Bevacizumab

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems

Cite this

Kim, G. A. ; Rim, T. H. ; Lee, Sungchul ; Byeon, S. H. ; Koh, H. J. ; Kim, S. S. ; Lee, C. S. / Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients. In: Eye (Basingstoke). 2015 ; Vol. 29, No. 6. pp. 732-741.
@article{a1747bca4f2d47829ed438ac9dde712b,
title = "Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients",
abstract = "PurposeTo investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients.MethodsWe retrospectively reviewed 42 eyes of CSC patients of symptom duration more than 3 months who received a single or multiple successive IVBs on an as-needed basis (0.05 ml, 1.25 mg). High responders (HRs) were defined as complete resolution of subretinal fluid (SRF) on spectral domain optical coherence tomography (SD-OCT). Moderate responders (MRs) were defined as SRF resolution of 50-99{\%} of pretreatment volume and poor responders (PRs) as SRF resolution <50{\%}. Clinical, SD-OCT, fluorescein, and indocyanine green angiography findings were analyzed to find factors associated with HR. Descriptive statistics for all demographic and clinical variables were calculated, and comparisons were made using Wilcoxon's matched-pairs signed-rank test, the Mann-Whitney U-test for means with continuous data, Pearson's χ 2 test, and Fisher's exact test for categorical data.ResultsThe mean number of IVB was 1.9. At postoperative 1 month, there were 10 (24{\%}) HRs, 18 (43{\%}) MRs, and 14 (33{\%}) PRs. At the last follow-up (the mean 8.6 months), there were 25 HRs (60{\%}), 9 MRs (21{\%}), and 8 PRs (19{\%}). Thicker subfoveal choroid (P=0.036), smaller lesion diameter (P=0.019), and better baseline best-corrected visual acuity (P=0.002) predicted HRs at postoperative 1 month. HR at the last follow-up was associated with classic pattern fluorescein angiography finding.ConclusionsSuboptimal effects of IVB on persistent CSC suggest primary IVB on selective cases with better vision, smaller lesion, and thicker choroid at baseline.",
author = "Kim, {G. A.} and Rim, {T. H.} and Sungchul Lee and Byeon, {S. H.} and Koh, {H. J.} and Kim, {S. S.} and Lee, {C. S.}",
year = "2015",
month = "6",
day = "12",
doi = "10.1038/eye.2015.58",
language = "English",
volume = "29",
pages = "732--741",
journal = "Eye",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "6",

}

Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients. / Kim, G. A.; Rim, T. H.; Lee, Sungchul; Byeon, S. H.; Koh, H. J.; Kim, S. S.; Lee, C. S.

In: Eye (Basingstoke), Vol. 29, No. 6, 12.06.2015, p. 732-741.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients

AU - Kim, G. A.

AU - Rim, T. H.

AU - Lee, Sungchul

AU - Byeon, S. H.

AU - Koh, H. J.

AU - Kim, S. S.

AU - Lee, C. S.

PY - 2015/6/12

Y1 - 2015/6/12

N2 - PurposeTo investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients.MethodsWe retrospectively reviewed 42 eyes of CSC patients of symptom duration more than 3 months who received a single or multiple successive IVBs on an as-needed basis (0.05 ml, 1.25 mg). High responders (HRs) were defined as complete resolution of subretinal fluid (SRF) on spectral domain optical coherence tomography (SD-OCT). Moderate responders (MRs) were defined as SRF resolution of 50-99% of pretreatment volume and poor responders (PRs) as SRF resolution <50%. Clinical, SD-OCT, fluorescein, and indocyanine green angiography findings were analyzed to find factors associated with HR. Descriptive statistics for all demographic and clinical variables were calculated, and comparisons were made using Wilcoxon's matched-pairs signed-rank test, the Mann-Whitney U-test for means with continuous data, Pearson's χ 2 test, and Fisher's exact test for categorical data.ResultsThe mean number of IVB was 1.9. At postoperative 1 month, there were 10 (24%) HRs, 18 (43%) MRs, and 14 (33%) PRs. At the last follow-up (the mean 8.6 months), there were 25 HRs (60%), 9 MRs (21%), and 8 PRs (19%). Thicker subfoveal choroid (P=0.036), smaller lesion diameter (P=0.019), and better baseline best-corrected visual acuity (P=0.002) predicted HRs at postoperative 1 month. HR at the last follow-up was associated with classic pattern fluorescein angiography finding.ConclusionsSuboptimal effects of IVB on persistent CSC suggest primary IVB on selective cases with better vision, smaller lesion, and thicker choroid at baseline.

AB - PurposeTo investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients.MethodsWe retrospectively reviewed 42 eyes of CSC patients of symptom duration more than 3 months who received a single or multiple successive IVBs on an as-needed basis (0.05 ml, 1.25 mg). High responders (HRs) were defined as complete resolution of subretinal fluid (SRF) on spectral domain optical coherence tomography (SD-OCT). Moderate responders (MRs) were defined as SRF resolution of 50-99% of pretreatment volume and poor responders (PRs) as SRF resolution <50%. Clinical, SD-OCT, fluorescein, and indocyanine green angiography findings were analyzed to find factors associated with HR. Descriptive statistics for all demographic and clinical variables were calculated, and comparisons were made using Wilcoxon's matched-pairs signed-rank test, the Mann-Whitney U-test for means with continuous data, Pearson's χ 2 test, and Fisher's exact test for categorical data.ResultsThe mean number of IVB was 1.9. At postoperative 1 month, there were 10 (24%) HRs, 18 (43%) MRs, and 14 (33%) PRs. At the last follow-up (the mean 8.6 months), there were 25 HRs (60%), 9 MRs (21%), and 8 PRs (19%). Thicker subfoveal choroid (P=0.036), smaller lesion diameter (P=0.019), and better baseline best-corrected visual acuity (P=0.002) predicted HRs at postoperative 1 month. HR at the last follow-up was associated with classic pattern fluorescein angiography finding.ConclusionsSuboptimal effects of IVB on persistent CSC suggest primary IVB on selective cases with better vision, smaller lesion, and thicker choroid at baseline.

UR - http://www.scopus.com/inward/record.url?scp=84930855821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930855821&partnerID=8YFLogxK

U2 - 10.1038/eye.2015.58

DO - 10.1038/eye.2015.58

M3 - Article

VL - 29

SP - 732

EP - 741

JO - Eye

JF - Eye

SN - 0950-222X

IS - 6

ER -